The clinical trial of the indigenously developed Covid-19 vaccine candidate Covaxin will be conducted in three phases, AIIMS director Randeep Guleria told reporters on Monday. Guleria, addressing the media, also said that the transmission of the virus in the capital, barring certain areas, seems to have hit its peak.
Read more here:: India News Times